Results 211 to 220 of about 66,016 (261)
Some of the next articles are maybe not open access.

MCL

Proceedings of the XIV Brazilian Symposium on Information Systems, 2018
Software measures are underused due to the difficulty of interpreting their results and associating them to software quality. Different environments, languages, and development methodologies require specific measures and range of values. Thus, this paper proposes MCL (Metrics-based Constraint Language), a language that allows to specify, for different ...
Christian Marlon Souza Couto   +3 more
openaire   +1 more source

Puma*Mcl-1 interaction is not sufficient to prevent rapid degradation of Mcl-1 [PDF]

open access: yesOncogene, 2005
Although Puma (p53 upregulated modulator of apoptosis) was known as a principal mediator of cell death in response to diverse apoptotic signals, the molecular mechanism underlying its proapoptotic regulation remains largely uncharacterized. Here we reported that myeloid cell leukemia-1 (Mcl-1), an anti-apoptotic member of the Bcl-2 family with a rapid ...
Yide Mei, Wenjing Du, Mian Wu
exaly   +3 more sources

Implementation of MCL for effective ICT

6th Joint IFIP Wireless and Mobile Networking Conference (WMNC), 2013
In this contemporary world, many new digital technologies are introduced every day. Every field in this world is influenced by these technologies which changes the traditional way of functioning. Education field is also forced to undergo the modernization and digitization.
R. D. Balaji   +3 more
openaire   +1 more source

Discovery of Hippo in MCL

Blood, 2010
In this issue of Blood , Hartmann and colleagues report on the results of a high-resolution genomic profiling study in a large series of MCL. Copy number alteration and expression data are amalgamated with clinical outcome. Their data confirm the critical role of the cell-cycle and DNA damage-
openaire   +2 more sources

Hitting the target in MCL

Blood, 2012
One of the major challenges in the evaluation of new therapies for lymphoma and other hematologic malignancies has been the ability to demonstrate changes in important biomarkers and pharmacodynamic end points in the tumor cell population.In this issue of Blood, Leonard et al provide an elegant evaluation of the cyclin-dependent kinase (cdk) inhibitor ...
openaire   +2 more sources

Mcl-1: the 1 in CLL

Blood, 2008
Although Mcl-1 has been established as a survival and maintenance protein during in vitro incubations of primary CLL cells, in this issue of Blood, Pepper and colleagues further demonstrate the association of Mcl-1 with other prognostic factors and the role of this antiapoptotic protein in disease progression and outcome for patients with CLL.
Varsha, Gandhi   +2 more
openaire   +2 more sources

Treatment of MCL Injury in Combined ACL/MCL Injury

2017
Combined ACL and MCL injuries are the most common combined ligament injuries of the knee. Traditional management of isolated MCL injuries has been conservative. However, grade III MCL injuries or those associated with the PMC can lead to rotational laxity that can significantly impact patient functionality.
Daniel Whelan   +4 more
openaire   +1 more source

Smoking and Mouse MCL Healing

Journal of Knee Surgery, 2010
Cigarette smoking has been shown to delay soft tissue healing and complicate musculoskeletal recovery. Its deleterious effects have been proven in bone and soft tissue, although to a much more limited fashion in ligament or tendon. We exposed 120 experimental mice to two cigarettes per day for 2 months and then induced a blunt medial collateral ...
Rick, Wright   +3 more
openaire   +2 more sources

Treatment of relapsed/refractory MCL

Blood
Abstract Mantle cell lymphoma (MCL) is a rare subtype of B-cell non-Hodgkin lymphoma that is clinically characterized by its heterogeneous behavior, with courses ranging from indolent to highly aggressive cases with limited prognosis.
Elisabeth Silkenstedt, Martin Dreyling
openaire   +2 more sources

Unraveling MCL-1 degradation

Cell Death & Differentiation, 2006
Department of Biochemistry, St. Jude Children’s Research Hospital, Memphis,TN 38105, USA* Corresponding author: JT Opferman, Department of Biochemistry, St. JudeChildren’s Research Hospital, 332 N. Lauderdale, Memphis, TN 38105, USA.Tel: þ1-901-495-5524; Fax: þ1-901-525-8025;E-mail: joseph.opferman@stjude ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy